TrialHeadache2021

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.